Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Systemic Sclerosis and Related Diseases

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the pathogenesis, clinical manifestations, and treatment of systemic sclerosis, with an emphasis on fibrosis, autoantibodies, pulmonary involvement, and the role of TGF-ß signaling. It also explores genetic markers, endothelial dysfunction, and various treatment approaches including immunosuppressive therapy for this complex autoimmune disease.

350
Works

How has Systemic Sclerosis and Related Diseases's publication output changed over time?

ScholarIQpublication output · 2003–2020

Output grew0% over the shown period — from 1 works in 2003 to 1 in 2020.

1
1
1
1
2
2
1
3
1
1
2003200720092011201320142015201720182020

What are the most-cited papers on Systemic Sclerosis and Related Diseases?

ScholarIQmost cited works
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population
Maureen D. Mayes, James V. Lacey, Jennifer Beebe‐Dimmer, Brenda W. Gillespie, B.C. Cooper, Timothy Laing, David Schottenfeld
S132787887. 2003934 Citations
Mapping and predicting mortality from systemic sclerosis
Muriel Elhaï, Christophe Meune, Marouane Boubaya, Jérôme Avouac, É. Hachulla, Alexandra Balbir‐Gurman, Gabriela Riemekasten, Paolo Airò, Beatriz Joven, Serena Vettori, Franco Cozzi, Susanne Ullman, László Czirják, Mohammed Tikly, Ulf Müller‐Ladner, Paola Caramaschi, Oliver Distler, Florenzo Iannone, Lidia P Ananieva, Roger Hesselstrand, Radim Bečvář, Armando Gabrielli, Nemanja Damjanov, Maria João Salvador, Valeria Riccieri, Carina Mihai, Gabriella Szűcs, Ulrich A. Walker, Nicolas Hunzelmann, Duška Martinović, Vanessa Smith, Carolina de Souza Müller, Carlomaurizio Montecucco, Daniela Opriș-Belinski, Francesca Ingegnoli, Panayiotis G. Vlachoyiannopoulos, Bojana Stamenković, Edoardo Rosato, Stefan Heitmann, Jörg H. W. Distler, Thierry Zénone, Matthias Seidel, Alessandra Vacca, Ellen De Langhe, Srđan Novak, Maurizio Cutolo, Luc Mouthon, Jörg Henes, Carlo Chizzolini, Carlos Alberto von Mühlen, Kamal Solanki, Simona Rednic, Lisa K. Stamp, Branimir Anić, Vera Ortiz-Santamaría, Maria De Santis, Şule Yavuz, Walter Alberto Sifuentes Giraldo, Emmanuel Chatelus, Jiří Štork, Jacob M. van Laar, Esthela Loyo, Paloma García de la Peña Lefebvre, Kilian Eyerich, Vanesa Cosentino, Juan José Alegre Sancho, Otylia Kowal‐Bielecka, Grégoire Rey, Marco Matucci‐Cerinic, Yannick Allanore
Annals of the Rheumatic Diseases. 2017698 CitationsOPEN ACCESS
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney, Beverly Welch, Maureen D. Mayes, Richard A. Nash, Leslie J. Crofford, Barry Eggleston, Sharon Castina, Linda M. Griffith, Julia Goldstein, Dennis Wallace, Oana Craciunescu, Dinesh Khanna, Rodney J. Folz, Jonathan Goldin, E. William St. Clair, James R. Seibold, Kristine Phillips, Shin Mineishi, Robert W. Simms, Karen K. Ballen, Mark H. Wener, George E. Georges, Shelly Heimfeld, Chitra Hosing, Stephen J. Forman, Suzanne Kafaja, Richard M. Silver, Leroy Griffing, Jan Storek, Sharon LeClercq, Richard Brasington, Mary Ellen Csuka, Christopher Bredeson, Carolyn A. Keever-Taylor, Robyn T. Domsic, M. Bashar Kahaleh, Thomas A. Medsger, Daniel E. Furst
New England Journal of Medicine. 2018595 CitationsOPEN ACCESS
Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease
Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, Michael D. Roth, Daniel E. Furst, Richard M. Silver, Jonathan Goldin, Edgar Arriola, Charlie Strange, Marcy B. Bolster, James R. Seibold, D. Riley, Vivien Hsu, John Varga, Dean E. Schraufnagel, Arthur C. Theodore, Robert W. Simms, Robert A. Wise, Fred Wigley, Barbara White, Virginia Steen, Charles A. Read, Maureen D. Mayes, Ed Parsley, Kamal K. Mubarak, M. Kari Connolly, Jeffrey A. Golden, Mitchell A. Olman, Barri J. Fessler, Naomi F. Rothfield, Mark L. Metersky, Dinesh Khanna, Ning Li, Gang Li
S93356601. 2007464 CitationsOPEN ACCESS
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
Lenny van Bon, Alsya J. Affandi, Jasper Broen, Romy Christmann, Renoud J. Marijnissen, Lukasz Stawski, Giuseppina Farina, Giuseppina Stifano, Allison L. Mathes, Marta Cossu, Michael York, Cindy Collins, Mark H. Wenink, Richard Huijbens, Roger Hesselstrand, Tore Saxne, Mike DiMarzio, Dirk M. Wuttge, Sandeep K. Agarwal, John D. Reveille, Shervin Assassi, Maureen D. Mayes, Yanhui Deng, Joost P.H. Drenth, Jacqueline de Graaf, Martin den Heijer, Cees G. M. Kallenberg, Marc Bijl, Arnoud Loof, Wim B. van den Berg, Leo A. B. Joosten, Vanessa Smith, Filip De Keyser, Rafaella Scorza, C. Lunardi, Piet L. C. M. van Riel, Madelon C Vonk, Waander L. van Heerde, Stephan Meller, Bernhard Homey, Lorenzo Beretta, Mark Roest, Maria Trojanowska, Robert Lafyatis, Timothy R. D. J. Radstake
New England Journal of Medicine. 2013457 CitationsOPEN ACCESS

Where is Systemic Sclerosis and Related Diseases research published, and who funds it?

ScholarIQvenues & funding sources

TOP JOURNALS

S132787887934
S93356601464
S58727509388

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Systemic Sclerosis and Related Diseases is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
20%
Hybrid
7%
Bronze
40%
Closed
33%

Related on ScholarIQ

SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX
Paper
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
Paper
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Paper
The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus
Paper
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Paper
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
Paper
470M+ articles · free account